Eliot Ward - May 19, 2025 UPC Weekly - ‘Off label’ and off the hook: UPC finds no infringement of second medical use patent 2025 Week 20 For many years, the EPO has recognised that the novelty and inventiveness of a ...
Joanna Smith - October 2, 2024 Mewburn Ellis: top tier firm Legal 500 2025 We are extremely proud to once again be ranked tier one for our patent and trade mark practices in ...
Joanna Smith - October 5, 2023 Mewburn Ellis: top tier firm Legal 500 2024 We are extremely proud to once again be ranked tier one for our patent and trade mark practices in ...
Eliot Ward - October 4, 2023 UPC at four months old - a review The UPC is now four months old and the Court of First Instance is already quite busy. As of 4 ...
Julie Carlisle - August 10, 2023 Mewburn Ellis team up with Support Dogs to sponsor an Assistance Dog This week (7 – 13 August 2023) is International Assistance Dog Week and this year we're excited to ...
Robert Watson - March 2, 2023 Julie Carlisle and Robert Watson in PharmaTimes — everything I own? Featured in PharmaTimes, Julie Carlisle and Robert Watson dig deep into the maelstrom of ...
Julie Carlisle - February 5, 2023 Meet the team: Julie Carlisle, Partner, Patent Attorney and Litigator in the Chemistry team, London As part of our 'meet the team' series, we talk to Julie Carlisle about her journey to becoming a ...
Jacqueline Murphy - November 29, 2022 Patent Litigation Trends in England & Wales - new report We are delighted to release our latest report Patent Litigation Trends in England and Wales.
Julie Carlisle - November 16, 2022 European validation strategies for pharmaceutical patents – an update In January 2021, we published our Special Report on EP validation strategies for pharmaceutical ...
Jacqueline Murphy - October 14, 2022 Mewburn Ellis: top tier firm Legal 500 2023 We are extremely proud to be ranked tier one for our patent and trade mark practices in the 2023 ...
Julie Carlisle - June 22, 2022 The surprising world of canine oncology Dog cancer specialist Dr Clare Knottenbelt reveals the insights derived from studying and treating ...
Sarah Kostiuk-Smith - June 21, 2021 Podcast with Sarah Kostiuk-Smith: Validation strategies for pharmaceutical patents in Europe Sarah Kostiuk-Smith, Partner and Patent Attorney at Mewburn Ellis (UPDATE 30 SEPTEMBER 2022: Sarah ...
Jacqueline Murphy - February 4, 2021 New Special Report: Validation Strategies for Pharmaceutical Patents in Europe We are excited to announce the launch of our new Validation Strategies for Pharmaceutical Patents ...
Julie Carlisle - July 5, 2020 Medicine's most wanted Will the world's most dangerous microbes soon meet their match? Forward finds out what's in the ...
Julie Carlisle - June 1, 2020 Is faster drug development likely to become the “new normal?” As part of our Thought Leaders series, Sarah Kostiuk-Smith explores whether faster drug development ...
Julie Carlisle - May 20, 2019 Protecting the ‘Trojan horse’ drug key to keeping a struggling field viable An Expert View column originally published in The Pharma Letter. Read the original article here. ...
Julie Carlisle - March 28, 2019 Dosage regimen patents: bruised but not beaten Ruling on the big pharma Actavis v ICOS case, the UK Supreme Court has found ICOS’s Cialis patent ...
